Sachem Capital Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Sachem Capital Corp. on October 20, 2020, covering events occurring between October 20 and October 23, 2020. The filing details the entry into a material definitive agreement and the consummation of a registered public offering of debt securities.
Key Financial Metrics
- Debt Issuance: The Company sold $14,000,000 aggregate principal amount of 7.75% Notes due 2025.
- Net Proceeds: The Company realized net proceeds of $13,545,000 from the sale.
- Underwriting Costs: Underwriting discounts and commissions totaled $455,000 (3.25% discount).
- Overallotment Option: Underwriters hold a 30-day option to purchase up to an additional $2,100,000 of Notes, expiring November 20, 2020.
- Liquidity Impact: The filing does not provide specific pre-offering cash balances or total liquidity figures; however, the transaction increased cash by the net proceeds amount.
Material Changes
The primary material change is the expansion of the Company's existing 7.75% Notes due 2025 series. This new issuance ranks equally in right of payment with the $14,363,750 of similar Notes issued in September 2020. The new Notes trade under the symbol "SCCC" on the NYSE American.
Outlook, Risks, and Management Commentary
Management consummated the offering to raise capital, with the transaction closing on October 23, 2020. The Notes were offered pursuant to a shelf registration statement (Form S-3) declared effective on February 5, 2020. The filing incorporates by reference the full text of the Underwriting Agreement and Indenture, which contain customary representations, warranties, covenants, and termination provisions. No specific forward-looking guidance or risk factors unique to this transaction are detailed in the text of this 8-K beyond standard legal disclaimers.
Investor Verification Checklist
- Verify the total outstanding principal of the 7.75% Notes due 2025 series (previously $14,363,750 plus the new $14,000,000).
- Confirm whether the underwriters exercised the $2,100,000 overallotment option by November 20, 2020.
- Review the Third Supplemental Indenture (Exhibit 4.1) for specific covenants and redemption terms applicable to the combined note series.
- Check subsequent filings for the use of proceeds and any impact on the Company's leverage ratios.